These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 30508183
21. Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation. Hu K, Liu D, Störk S, Herrmann S, Oder D, Ertl G, Voelker W, Weidemann F, Nordbeck P. J Card Fail; 2017 Jun; 23(6):434-443. PubMed ID: 27890771 [Abstract] [Full Text] [Related]
22. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation. Amat-Santos IJ, Castrodeza J, Nombela-Franco L, Muñoz-García AJ, Gutiérrez-Ibanes E, de la Torre Hernández JM, Córdoba-Soriano JG, Jiménez-Quevedo P, Hernández-García JM, González-Mansilla A, Ruano J, Tobar J, Del Trigo M, Vera S, Puri R, Hernández-Luis C, Carrasco-Moraleja M, Gómez I, Rodés-Cabau J, San Román JA. Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280 [Abstract] [Full Text] [Related]
23. Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction: Results of the Multicenter TOPAS Study (True or Pseudo-Severe Aortic Stenosis). Dahou A, Magne J, Clavel MA, Capoulade R, Bartko PE, Bergler-Klein J, Sénéchal M, Mundigler G, Burwash I, Ribeiro HB, O'Connor K, Mathieu P, Baumgartner H, Dumesnil JG, Rosenhek R, Larose E, Rodés-Cabau J, Pibarot P. JACC Cardiovasc Interv; 2015 Apr 20; 8(4):588-96. PubMed ID: 25819185 [Abstract] [Full Text] [Related]
24. Effect of Preoperative Tricuspid and/or Mitral Regurgitation on Development of Late Right-Sided Heart Failure After Insertion of the HeartWare Left Ventricular Assist Device. Gonzalez-Fernandez O, Bouzas-Cruz N, Ferrera C, Woods A, Robinson-Smith N, Tovey S, Parry G, MacGowan GA, Schueler S. Am J Cardiol; 2020 Jan 15; 125(2):236-243. PubMed ID: 31767121 [Abstract] [Full Text] [Related]
25. Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction. Kajimoto K, Sato N, Takano T, investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) registry. Eur J Heart Fail; 2016 Aug 15; 18(8):1051-9. PubMed ID: 27212582 [Abstract] [Full Text] [Related]
26. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure. Tang PC, Haft JW, Romano MA, Bitar A, Hasan R, Palardy M, Wu X, Aaronson KD, Pagani FD. J Thorac Cardiovasc Surg; 2020 Mar 15; 159(3):897-905.e4. PubMed ID: 31101350 [Abstract] [Full Text] [Related]
27. Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction. Agricola E, Stella S, Gullace M, Ingallina G, D'Amato R, Slavich M, Oppizzi M, Ancona MB, Margonato A. Eur J Heart Fail; 2012 Aug 15; 14(8):902-8. PubMed ID: 22552182 [Abstract] [Full Text] [Related]
28. Tricuspid regurgitation in acute heart failure: is there any incremental risk? Mutlak D, Lessick J, Khalil S, Yalonetsky S, Agmon Y, Aronson D. Eur Heart J Cardiovasc Imaging; 2018 Sep 01; 19(9):993-1001. PubMed ID: 29346535 [Abstract] [Full Text] [Related]
29. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Primary Mitral Regurgitation and Preserved Systolic Function Undergoing Mitral Valve Surgery. Alashi A, Mentias A, Patel K, Gillinov AM, Sabik JF, Popović ZB, Mihaljevic T, Suri RM, Rodriguez LL, Svensson LG, Griffin BP, Desai MY. Circ Cardiovasc Imaging; 2016 Jul 01; 9(7):. PubMed ID: 27342145 [Abstract] [Full Text] [Related]
30. Lack of Increased Cardiovascular Risk due to Functional Tricuspid Regurgitation in Patients with Left-Sided Heart Disease. Mutlak D, Khoury E, Lessick J, Kehat I, Agmon Y, Aronson D. J Am Soc Echocardiogr; 2019 Dec 01; 32(12):1538-1546.e1. PubMed ID: 31624025 [Abstract] [Full Text] [Related]
31. Echocardiographic assessment of mitral stenosis and its associated valvular lesions in 205 patients and lack of association with mitral valve prolapse. Sagie A, Freitas N, Chen MH, Marshall JE, Weyman AE, Levine RA. J Am Soc Echocardiogr; 1997 Mar 01; 10(2):141-8. PubMed ID: 9083969 [Abstract] [Full Text] [Related]
32. Mitral Valve Repair Without Repair of Moderate Tricuspid Regurgitation. De Bonis M, Lapenna E, Pozzoli A, Nisi T, Giacomini A, Calabrese M, La Canna G, Pappalardo F, Miceli A, Glauber M, Barili F, Alfieri O. Ann Thorac Surg; 2015 Dec 01; 100(6):2206-12. PubMed ID: 26330009 [Abstract] [Full Text] [Related]
33. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk. Besler C, Blazek S, Rommel KP, Noack T, von Roeder M, Luecke C, Seeburger J, Ender J, Borger MA, Linke A, Gutberlet M, Thiele H, Lurz P. JACC Cardiovasc Interv; 2018 Jun 25; 11(12):1142-1151. PubMed ID: 29929635 [Abstract] [Full Text] [Related]
34. Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure. Pagnesi M, Riccardi M, Chiarito M, Stolfo D, Baldetti L, Lombardi CM, Colombo G, Inciardi RM, Tomasoni D, Loiacono F, Maccallini M, Villaschi A, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Cappelletti AM, Sinagra G, Pini D, Metra M, Adamo M. J Cardiovasc Med (Hagerstown); 2024 Mar 01; 25(3):200-209. PubMed ID: 38251453 [Abstract] [Full Text] [Related]
35. Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair. Kortekaas KA, Hoogslag GE, de Boer RA, Dokter MM, Versteegh MI, Braun J, Marsan NA, Verwey HF, Delgado V, Schalij MJ, Klautz RJ. Eur J Heart Fail; 2013 Sep 01; 15(9):1011-8. PubMed ID: 23576289 [Abstract] [Full Text] [Related]
36. Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis. Tomasoni D, Aimo A, Porcari A, Bonfioli GB, Castiglione V, Saro R, Di Pasquale M, Franzini M, Fabiani I, Lombardi CM, Lupi L, Mazzotta M, Nardi M, Pagnesi M, Panichella G, Rossi M, Vergaro G, Merlo M, Sinagra G, Emdin M, Metra M, Adamo M. Eur Heart J Cardiovasc Imaging; 2024 Jun 28; 25(7):1007-1017. PubMed ID: 38497794 [Abstract] [Full Text] [Related]
37. Severe mitral regurgitation is associated with increased copeptin levels in heart failure with reduced ejection fraction. Kılıcgedık A, Eroglu E, Kahvecı G, Isgandarov K, Acar E, Ozturk S, Zehir R, Kulahcıoglu S, Toprak C, Yaman A, Izgı IA, Kirma C. Kardiol Pol; 2017 Jun 28; 75(12):1307-1314. PubMed ID: 28715068 [Abstract] [Full Text] [Related]
38. Natural history of coexistent tricuspid regurgitation in patients with degenerative mitral valve disease: implications for future guidelines. Goldstone AB, Howard JL, Cohen JE, MacArthur JW, Atluri P, Kirkpatrick JN, Woo YJ. J Thorac Cardiovasc Surg; 2014 Dec 28; 148(6):2802-9. PubMed ID: 25218532 [Abstract] [Full Text] [Related]
39. Functional valvular incompetence in decompensated heart failure: noninvasive monitoring and response to medical management. Campos PC, D'Cruz IA, Johnson LS, Malhotra A, Ramanathan KB, Weber KT. Am J Med Sci; 2005 May 28; 329(5):217-21. PubMed ID: 15894862 [Abstract] [Full Text] [Related]
40. Outcome and undertreatment of mitral regurgitation: a community cohort study. Dziadzko V, Clavel MA, Dziadzko M, Medina-Inojosa JR, Michelena H, Maalouf J, Nkomo V, Thapa P, Enriquez-Sarano M. Lancet; 2018 Mar 10; 391(10124):960-969. PubMed ID: 29536860 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]